1
|
Hu P, Peters BK, Malapit CA, Vantourout JC, Wang P, Li J, Mele L, Echeverria PG, Minteer SD, Baran PS. Electroreductive Olefin-Ketone Coupling. J Am Chem Soc 2020; 142:20979-20986. [PMID: 33259715 DOI: 10.1021/jacs.0c11214] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
A user-friendly approach is presented to sidestep the venerable Grignard addition to unactivated ketones to access tertiary alcohols by reversing the polarity of the disconnection. In this work a ketone instead acts as a nucleophile when adding to simple unactivated olefins to accomplish the same overall transformation. The scope of this coupling is broad as enabled using an electrochemical approach, and the reaction is scalable, chemoselective, and requires no precaution to exclude air or water. Multiple applications demonstrate the simplifying nature of the reaction on multistep synthesis, and mechanistic studies point to an intuitive mechanism reminiscent of other chemical reductants such as SmI2 (which cannot accomplish the same reaction).
Collapse
Affiliation(s)
- Pengfei Hu
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla 92037, California, United States.,NSF Center for Synthetic Organic Electrochemistry, University of Utah, 315 South 1400 East, Salt Lake City 84112, Utah, United States
| | - Byron K Peters
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla 92037, California, United States.,NSF Center for Synthetic Organic Electrochemistry, University of Utah, 315 South 1400 East, Salt Lake City 84112, Utah, United States
| | - Christian A Malapit
- Department of Chemistry, University of Utah, 315 South 1400 East, Room 2020, Salt Lake City 84112, Utah, United States.,NSF Center for Synthetic Organic Electrochemistry, University of Utah, 315 South 1400 East, Salt Lake City 84112, Utah, United States
| | - Julien C Vantourout
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla 92037, California, United States.,NSF Center for Synthetic Organic Electrochemistry, University of Utah, 315 South 1400 East, Salt Lake City 84112, Utah, United States
| | - Pan Wang
- Center for Excellence of Process Science, Asymchem Laboratories (Tianjin) Co., Ltd. TEDA, Tianjin 300457, P. R. China
| | - Jinjun Li
- Center for Excellence of Process Science, Asymchem Laboratories (Tianjin) Co., Ltd. TEDA, Tianjin 300457, P. R. China
| | - Lucas Mele
- Minakem Recherche, 145 Chemin des Lilas, Beuvry-la-Forêt 59310, France
| | | | - Shelley D Minteer
- Department of Chemistry, University of Utah, 315 South 1400 East, Room 2020, Salt Lake City 84112, Utah, United States.,NSF Center for Synthetic Organic Electrochemistry, University of Utah, 315 South 1400 East, Salt Lake City 84112, Utah, United States
| | - Phil S Baran
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla 92037, California, United States.,NSF Center for Synthetic Organic Electrochemistry, University of Utah, 315 South 1400 East, Salt Lake City 84112, Utah, United States
| |
Collapse
|
2
|
Carlberg C, Molnár F, Mouriño A. Vitamin D receptor ligands: the impact of crystal structures. Expert Opin Ther Pat 2012; 22:417-35. [PMID: 22449247 DOI: 10.1517/13543776.2012.673590] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
INTRODUCTION In the past years, the biologically active form of vitamin D(3), 1α,25-dihydroxyvitamin D(3) (1α,25(OH)(2)D(3)), has received large appreciation due to the broad physiological impact of the hormone and its nuclear receptor, the transcription factor vitamin D receptor (VDR). Recently, the understanding of VDR actions has progressed greatly, due to VDR crystal structures with various ligands. AREAS COVERED This review will present and discuss new synthetic agonistic and antagonistic 1α,25(OH)(2)D(3) analogs in the context of the recent insights provided by VDR crystal structures. EXPERT OPINION During the last 5 years, a large number of new 1α,25(OH)(2)D(3) analogs, many of which have an interesting functional profile, have been patented. Moreover, for a surprisingly high number of 1α,25(OH)(2)D(3) analogs, the crystal structure data of their complex with the VDR is available. This structural information provides important insight into the functional potential of the VDR ligands and explains their agonistic and antagonistic action. However, so far, only for a few VDR ligands, a rational design, based on crystal structure information, has been applied. The design of future analogs may also take the specificity of co-factor interaction into account, in order to create selective VDR modulators.
Collapse
Affiliation(s)
- Carsten Carlberg
- University of Eastern Finland, School of Medicine, Institute of Biomedicine, Kuopio, Finland.
| | | | | |
Collapse
|
3
|
Plonska-Ocypa K, Sibilska I, Sicinski RR, Sicinska W, Plum LA, DeLuca HF. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation. Bioorg Med Chem 2011; 19:7205-20. [PMID: 22018918 DOI: 10.1016/j.bmc.2011.09.048] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2011] [Revised: 09/21/2011] [Accepted: 09/24/2011] [Indexed: 11/30/2022]
Abstract
As a continuation of our studies focused on the vitamin D compounds lacking the C,D-hydrindane system, 13,13-dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D(3) (2, 2MD) were prepared by total synthesis. The known cyclohexanone 30, a precursor of the desired A-ring phosphine oxide 11, was synthesized starting with the keto acetal 13, whereas the aldehyde 12, constituting an acyclic 'upper' building block, was obtained from the isomeric esters 34, prepared previously in our laboratory. The commercial 1,4-cyclohexanedione monoethylene ketal (13) was enantioselectively α-hydroxylated utilizing the α-aminoxylation process catalyzed by l-proline, and the introduced hydroxy group was protected as a TBS, TPDPS, and SEM ether. Then the keto group in the obtained compounds 15-17 was methylenated and the allylic hydroxylation was performed with selenium dioxide and pyridine N-oxide. After separation of the isomers, the newly introduced hydroxy group was protected and the ketal group hydrolyzed to yield the corresponding protected (3R,5R)-3,5-dihydroxycyclohexanones 30-32. The esters 34, starting compounds for the C,D-fragment 12, were first α-methylated, then reduced and the resulted primary alcohols 36 were deoxygenated using the Barton-McCombie protocol. Primary hydroxy group in the obtained diether 38 was deprotected and oxidized to furnish the aldehyde 12. The Wittig-Horner coupling of the latter with the anion of the phosphine oxide 11, followed by hydroxyl deprotection furnished two isomeric 13,13-dimethyl-des-C,D analogues of 2MD (compounds 10 and 42) differing in configuration of their 7,8-double bond. Pure vitamin D analogues were isolated by HPLC and their biological activity was examined. The in vitro tests indicated that, compared to the analogue 7, unsubstituted at C-13, the synthesized vitamin D analogue 10 showed markedly improved VDR binding ability, significantly enhanced HL-60 differentiation activity as well as increased transcriptional potency. Docking simulations provided a rational explanation for the observed binding affinity of these ligands to the VDR. Biological in vivo tests proved that des-C,D compound 10 retained some intestinal activity. Its geometrical isomer 42 was devoid of any biological activity.
Collapse
Affiliation(s)
- Katarzyna Plonska-Ocypa
- Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA
| | | | | | | | | | | |
Collapse
|
4
|
Plonska-Ocypa K, Sicinski RR, Plum LA, Grzywacz P, Frelek J, Clagett-Dame M, DeLuca HF. 13-Methyl-substituted des-C,D analogs of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): Synthesis and biological evaluation. Bioorg Med Chem 2009; 17:1747-63. [DOI: 10.1016/j.bmc.2008.11.082] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2008] [Revised: 11/19/2008] [Accepted: 11/23/2008] [Indexed: 01/07/2023]
|
5
|
Brown WM. Vitamin D, vitamin D analogs (deltanoids) and prostate cancer. Expert Rev Clin Pharmacol 2008; 1:803-13. [PMID: 24410609 DOI: 10.1586/17512433.1.6.803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
'Vitamin D' is a generic term for a family of secosteroids, members of which bind to the vitamin D receptor. Calcitriol, the active form of vitamin D, has antiproliferative effects on many tumor cells. However, clinical use of calcitriol in cancer prevention or therapy is limited because it induces hypercalcemia at the necessary supraphysiological doses. The anti-tumor effects of vitamin D analogs (deltanoids) have been researched extensively; more than 3000 deltanoids have now been described. Prostate cancer is more common in northern geographic regions; mortality decreases with exposure to sunlight. As UV light is necessary for vitamin D synthesis in the skin, it has long been dogma that vitamin D is involved. This review concerns deltanoids that have been assessed for use in treating or preventing prostate cancer.
Collapse
Affiliation(s)
- William M Brown
- VaxDesign Corp., 12612 Challenger Parkway, Suite 365, Orlando, FL 32826, USA.
| |
Collapse
|